Advanced in Attention Deficit Hyperactivity Disorder (ADHD)

Maibritt B. Giacobini

Malmoe, M, SE 
Advanced in Attention Deficit Hyperactivity Disorder (ADHD)
Malmoe, M, SE 
OverviewLocationsClinical Research

Overview

Maibritt Giacobini practices in Malmoe, Sweden. Giacobini is rated as an Advanced expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Their top areas of expertise are Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Transient Tic Disorder.

Their clinical research consists of co-authoring 15 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles and participated in 1 clinical trial in the study of Attention Deficit Hyperactivity Disorder (ADHD).

Locations

Malmoe, M, Sweden
Other Locations
Stockholm, AB, Sweden
Rinkeby, AB 16374, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation Followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attention-deficit/Hyperactivity Disorder
A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation Followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 08, 2025
Intervention Type: Drug, Other
Study Drugs: Guanfacine hydrochloride (TAK-503), Atomoxetine hydrochloride
Study Phase: Phase 4

15 Total Publications

Association between prenatal exposure to Crohn's disease and offspring psychiatric regulatory disturbances.
Association between prenatal exposure to Crohn's disease and offspring psychiatric regulatory disturbances.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: July 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Giacobini's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile